Untitled

NUR 310 Study Outline Micro-Exam 6 Fall 2025

Concept: Tissue Integrity

Exemplar: Perioperative
  • Overview: The perioperative experience includes the preoperative, intraoperative, and postoperative phases of a patient's surgical journey. Effective nursing care during these phases is critical to ensuring patient safety and minimizing the risk of complications.
Recognize Cues: Risk Factors
  • Comorbidities: Conditions that predispose patients to surgical risks include:
      - Diabetes Mellitus: Increases risk for infection and delayed healing.
      - Cardiovascular Disease: Heightens risk for fluid overload and venous thromboembolism (VTE).
      - Respiratory Diseases (e.g., COPD, asthma): Elevates risk for atelectasis and hypoxemia.
  • Obesity: Increases strain on cardiac and pulmonary systems, leading to a heightened risk of wound dehiscence and a delayed recovery from anesthesia.
  • Age: Older adults present a higher risk for dehydration, sensory and cognitive deficits, and adverse anesthesia reactions due to decreased renal and hepatic function.
  • Medications and Substances: Tobacco, alcohol, and anticoagulant use can elevate risks for bleeding, infections, and cardiovascular issues.
  • Allergies: Identification of allergies is vital, such as an egg or soybean allergy which contraindicates the use of propofol for anesthesia.
Safety Measures
  • Informed Consent: Nurses are responsible for witnessing the patient’s signature and ensuring they understand the procedure and consent voluntarily.
  • Universal Protocol and Surgical Timeout: A National Patient Safety Goal to verify patient identity and confirm correct surgical site and procedure immediately before incision.
  • NPO Status: Maintaining a "nothing by mouth" status is crucial to prevent regurgitation and aspiration during anesthesia.
  • Preoperative Checklist: Check baseline vital signs, ensure signed consent, and confirm removal of jewelry or prosthetics.
Clinical Manifestations of Surgical Complications
  • Respiratory Complications: Includes atelectasis (decreased oxygen saturation), airway obstruction (stridor, snoring), and hypoventilation.
  • Cardiovascular Complications: Signs of hypovolemic shock include hypotension, tachycardia, and restlessness; DVT presents as edema, warmth, or pain in an extremity; fluid overload symptoms may develop.
  • Gastrointestinal Complications: Paralytic ileus is characterized by absent bowel sounds, nausea, and abdominal distension.
  • Wound Complications: Dehiscence (spontaneous wound opening) and evisceration (protrusion of internal organs), alongside signs of infection (purulent drainage, fever).
  • Malignant Hyperthermia: A life-threatening emergency characterized by muscle rigidity, tachycardia, and a rapid increase in body temperature during anesthesia.
Priority Nursing Assessments
  • Full Body Assessment: Focus on Airway, Breathing, and Circulation (ABCs).
  • Vital Signs Monitoring: Trends in blood pressure, heart rate, and oxygen saturation should be monitored every 15 minutes.
  • Neurologic Status: Assess level of consciousness and orientation using the Aldrete Score to determine discharge readiness from the PACU.
  • Fluid Status: Monitor intake/output (I&O); urinary output below 30 mL/hr may indicate hypovolemia or renal injury.
  • Surgical Site Inspection: Check dressings for drainage (noting color and amount) and patency of drains (e.g., Jackson-Pratt, Hemovac).
Nursing and Collaborative Interventions
  • Respiratory Support: Encourage deep breathing, coughing, and use of an incentive spirometer every 1-2 hours to prevent atelectasis.
  • VTE Prophylaxis: Utilize sequential compression devices (SCDs), anti-embolism stockings, and promote early ambulation.
  • Infection Control: Administer prophylactic antibiotics within one hour of the surgical incision, maintain sterile techniques during dressing changes.
  • Proper Positioning: Reposition patients every 2 hours, avoiding pillow placement under knees to facilitate venous return.
  • Pain Management: Assess pain levels using standardized scales and administer pharmacological (e.g., PCA pump) and non-pharmacological relief options (e.g., distraction, imagery).
Client Education
  • Postoperative Complication Prevention: Educate patients on performing splinting with a pillow over incisions when coughing to minimize pain and prevent dehiscence.
  • Activity and Nutrition: Instruct on activity restrictions and emphasize a diet high in protein and Vitamin C for wound healing.
  • Medication Safety: Provide instructions on new prescriptions' purposes, side effects, and when to resume pre-surgery medications like anticoagulants.
  • Home Safety: Emphasize fall prevention for older adults by installing handrails, removing loose rugs, and ensuring adequate lighting.
  • When to Call the Provider: Teach patients to recognize "red flag" symptoms such as uncontrolled pain, unusual drainage at incision sites, or fever.

Concept: Inflammation

Definition
  • Inflammation: An immunologic defense mechanism against tissue injury, infection, or allergy, characterized by both systemic and localized responses depending on duration (acute vs. chronic).
Classic Signs of Inflammation
  • Five classic signs include:
      - Pain: Resulting from pressure on pain receptors.
      - Swelling: Due to fluid extravasation.
      - Redness: Caused by increased blood flow from proinflammatory hormones.
      - Heat: Localized temperature increase from enhanced blood flow.
      - Loss of Function: Due to pain and inflammation affecting mobility.
Diagnostic Markers
  • Blood Tests: Common tests to identify inflammation include:
      - Complete Blood Count (CBC) with differential.
      - C-Reactive Protein (CRP).
      - Erythrocyte Sedimentation Rate (ESR).
Exemplar: Osteoarthritis and Rheumatoid Arthritis
Disease Process
  • Osteoarthritis (OA): A slow, progressive, non-inflammatory joint disorder characterized by cartilage destruction resulting in bone spur growth. Presents as bone on bone contact.
  • Rheumatoid Arthritis (RA): A chronic systemic autoimmune condition characterized by inflammation of the synovial membrane, leading to joint erosion.
Symmetrical and Involvement Patterns
  • OA: Typically asymmetrical, affecting weight-bearing joints (knees, hips).
  • RA: Presents symmetrically starting in small joints (fingers, wrists), may involve systemic manifestations affecting the lungs or heart.
Pain and Stiffness Patterns
  • OA: Morning stiffness usually subsides within 30 minutes; pain often alleviated by rest in early stages.
  • RA: Morning stiffness lasts over 30-60 minutes; pain persists even at rest.
Recognize Cues: Risk Factors
  • Osteoarthritis: Key risks include aging (over 60), obesity, female sex, and history of joint injuries.
  • Rheumatoid Arthritis: Female predominance (3:1), age range (30-60), genetic predisposition, stress, smoking, environmental factors, and a small body frame.
Clinical Manifestations
  • OA Manifestations: Includes Heberden’s nodes (distal joints), Bouchard’s nodes (proximal joints), joint crepitus, and limping due to localized pain.
  • RA Manifestations: Joint swelling, warmth, and erythema, with late-stage deformities (swan neck, boutonnière). Systemic signs include fatigue, fever, anorexia.
Priority Nursing Assessments
  • Physical Exam: Assess joints for tenderness, swelling, and range of motion; prioritize RA assessment for systemic involvement (e.g., pleuritic pain or Sjögren’s syndrome).
  • Lab Evaluation: Monitor for elevated ESR, CRP, and check for positive Rheumatoid Factor (RF) and Antinuclear Antibody (ANA) titer to confirm RA.
  • Functional Status: Evaluate the ability to perform Activities of Daily Living (ADLs) and assess fatigue levels.
Priority Interventions
  • Pain Management: Offer pharmacological (NSAIDs, DMARDs) and non-pharmacological relief options. In RA, DMARDs like methotrexate slow disease progression.
  • Joint Protection: Encourage activity-rest balance, rest joints in functional positions during acute inflammation, and use splints or braces judiciously.
  • Thermal Therapy: Apply ice for acute inflammation (limited to 20 minutes) and heat to relieve stiffness.
Client Education for Management
  • Safety and Mobility: Advise OA patients to install elevated toilet seats and use assistive devices to lessen joint strain; recommend morning high-energy activity.
  • Nutritional Support: Advocate for balanced diets and weight control for joint stress reduction; RA patients should avoid processed foods/refined sugars triggering inflammation.
  • Joint-Saving Techniques: Instruct to utilize larger joints instead of smaller (e.g., using both hands) and Velcro closures over buttons.
  • Medication Safety: Educate RA patients on methotrexate risks (e.g., report bleeding, infection signs) and the need for alcohol avoidance due to hepatotoxicity.

Pharmacology/Medications

Drug Therapy for Inflammation
Antigout/Antihyperuricemic: Allopurinol (Zyloprim)
  • Therapeutic Use: Treats chronic gout, frequent gout attacks, and hyperuricemia from cancer chemotherapy or blood dyscrasias.
  • Administration: Oral or IV infusion over 30-60 minutes, requiring at least 3 L fluid intake/day. Monitor baseline uric acid and liver/kidney function periodically.
  • Adverse Drug Reactions: May include hypersensitivity syndrome (fever, rash), gastrointestinal distress, CNS effects (drowsiness, headache), and bone marrow suppression (anemia, agranulocytosis); long-term use may lead to cataracts.
  • Nursing Interventions: Monitor for hypersensitivity signs, liver/kidney function; CBC for bone marrow suppression; assist ambulation for vertigo.
  • Client Instructions: Report fever, rash, abdominal pain, or blood in urine; minimize sunlight exposure to eyes and obtain regular eye exams.
  • Contraindications & Precautions: Use caution with bone marrow depression, liver/renal dysfunction, or peptic ulcer disease.
  • Interactions: Increases warfarin anticoagulant effects; concurrent use with mercaptopurine, theophylline, or azathioprine increases toxicity risk.
Glucocorticoids: Prednisone (Deltasone)
  • Therapeutic Use: Relief of pain/inflammation in rheumatoid arthritis, allergic reactions, and prevention of organ rejection.
  • Administration: Oral, IV, IM, subcutaneous, topical, or inhaled. Typically large doses on the first day, with a tapering schedule for long-term use.
  • Adverse Drug Reactions: Includes adrenal suppression, hyperglycemia, electrolyte imbalances, osteoporosis, GI bleeding, and fat redistribution causing "moon face" and "buffalo hump."
  • Nursing Interventions: Monitor for adrenal insufficiency signs, glucose levels, GI bleeding, and signs of fluid retention.
  • Client Instructions: Gradually taper the dose; report hyperglycemia, weight gain, or edema; encourage calcium and vitamin D intake to prevent osteoporosis.
  • Contraindications & Precautions: Contraindicated in systemic fungal infections or cataracts; use caution in cardiac issues, peptic ulcer disease, diabetes, and hypertension.
  • Interactions: Increased hypokalemia risk with potassium-depleting diuretics; concurrent NSAID use heightens gastrointestinal bleeding risk.
Drug Therapy for Rheumatoid Arthritis
Nonbiologic (Traditional) DMARDs: Methotrexate (Rheumatrexate) & Leflunomide (Arava)
  • Therapeutic Use: Decreases joint inflammation, joint damage, and slows disease progression; methotrexate is also used in oncology for cancer.
  • Administration: Methotrexate is given weekly for RA through oral, subcutaneous, or intramuscular routes; doses start low and increase as needed.
  • Nursing Interventions: Monitor lab values for blood counts due to risk of bone marrow suppression; perform liver function tests, assess for jaundice and respiratory distress.
  • Adverse Drug Reactions: Include bone marrow suppression, infection risk, hepatotoxicity, GI ulceration, and pulmonary fibrosis; common side effects are dizziness, headaches, nausea, vomiting; both drugs are teratogenic.
  • Client Instructions: Maintain hydration (2 L/day); report skin/eye yellowing, infection signs, unusual bleeding, or stool changes; effective contraception for childbearing-aged clients; avoid alcohol.
  • Contraindications & Precautions: Contraindicated in pregnancy/breastfeeding; also contraindicated in liver/renal insufficiency, hepatitis, active infections; caution in ulcerative colitis.
  • Interactions: Methotrexate toxicity risk increases with NSAIDs, salicylates, sulfonamides; may reduce serum digoxin; increases bleeding risk when used with warfarin; alcohol increases hepatotoxicity.
Biologic DMARDs: Etanercept (Enbrel) & Adalimumab (Humira)
  • Therapeutic Use: TNF antagonists preventing inflammatory reactions in joints.
  • Administration (Etanercept): Subcutaneous injection once weekly; monitor injection site for reaction.
  • Adverse Drug Reactions: May include injection site reactions, upper respiratory infections, abdominal pain, and pancytopenia; high latent TB reactivation risk.
  • Nursing Interventions: TB screening prior to therapy, monitor signs of infection and liver enzyme levels throughout treatment.
  • Client Instructions: Report any infection signs and persistent injection site reactions; ensure vaccinations are current pre-therapy.
  • Contraindications & Precautions: Not suitable for active infections, hematologic diseases, or malignancies; contraindicated in central nervous system demyelinating disorders.
  • Interactions: Concurrent chemotherapeutic drug use increases bone marrow suppression risk; avoid live vaccines during treatment.
General Notes about Inflammation
  • Inflammation serves as a protective mechanism of the immune system. While it indicates a functioning immune response, prolonged inflammation can cause tissue damage.
  • The suffix “-itis” signifies inflammation.
  • CRP and ESR levels are common measures used to evaluate inflammation, indicating active inflammatory processes in the body.